WinstonWınston
Back
OrthoPediatrics logo

OrthoPediatrics

KIDS
33
Medical - Devices · Healthcare
Price
$25.65
-0.58 (-2.21%)
Market Cap
$658.8M
Exchange
NASDAQ
Winston Score
33
Winston is serious
Below-average fundamentals — multiple weak pillars.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Mixed
Growth
Mixed
Cash Flow
Weak
Stability
Good
Valuation
Data not available

Share count rising — dilution

+21.8% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 19.3M (2021) → 23.5M (2025)

Winston Score History

The full picture

OrthoPediatrics makes medical devices specifically designed for children who need bone and joint surgery. Its products include surgical implants, braces, and instruments used to treat conditions like scoliosis, broken bones, and limb deformities in kids. The company focuses almost entirely on pediatric orthopedics, which is a narrow but underserved niche — most adult orthopedic devices do not fit children's smaller bodies.

The company sells its products to hospitals and pediatric orthopedic surgeons, primarily in the United States but also in international markets. It generates revenue mainly through direct sales of implants and instruments, often using a loaner kit model where sets of tools are placed with hospitals. With a gross margin near 74%, the underlying product economics are solid, but the company is not yet profitable at the operating level. The key growth driver is expanding its product portfolio and international reach, while the main risk is that its small size makes it vulnerable to competition from larger medical device companies entering the pediatric space.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+15.4% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

+0.0% YoY

YoY Growth Rate

Slow EPS growth

R&D Spend

$9M/ year

Declining (-18% vs prior year)

3.9% of revenue

Below sector average (18%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

33.6%ownership

Flat

Insider ownership roughly steady over the past year

Cash Runway

~4 years

$46M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

$46M cash & investments at current burn rate

Growth context

OrthoPediatrics is growing revenue at 15% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
74.3%
Premium pricing power — 74.3% gross margin
Profit after running costs
Operating Margin
-5.8%
Losing money on operations — -5.8%
Return on the money invested
ROCE
-5.2%
Weak — -5.2% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+14.5%
Fast-growing sales (+14.5% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
2/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
-0.7%
Burning cash (-0.7%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.27
Conservative — low debt load (0.27)
Covers its interest
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial